Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT01175486
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Registry
-
NCT01175486
-
- Other papers using this trial's data
- Renal Outcomes of Pioglitazone Compared with Acarbose in Diabetic Patients: A Randomized Controlled Study
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Taiwan
- Registry status
- Unknown status
Technical summary
Registry record NCT01175486. Randomized; no masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2012-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy
- Condition
- Diabetes
- Intervention (Drug)
- Actos (Pioglitazone)
- Intervention (Drug)
- Acarbose
- Lead sponsor
- Taipei Veterans General Hospital, Taiwan
Record details
- Record id
cardio:ct-nct01175486- Content hash
1cb76793354a42c4645868aa291dfacbe20595fdc3bfef671e7e902d3318d99b